106 institutions reported holding $268.7M of SAB BIOTHERAPEUTICS INC (SABS) in SEC 13F filings for 2026-06-30. Largest institutional holders: Caligan Partners LP ($31.1M), Vivo Capital, LLC ($28.5M), PERCEPTIVE ADVISORS LLC ($25.8M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($25.0M), RA CAPITAL MANAGEMENT, L.P. ($17.2M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30